ClinicalMetric / Countries / Japan / neoplasms endometrial
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

neoplasms endometrial Clinical Trials in Japan

Active clinical trials for neoplasms endometrial with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT07286331 Phase 3
Recruiting

A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)

Enrollment
600 pts
Country
🇯🇵 Japan
GlaxoSmithKline
View Trial →

Frequently Asked Questions

How many neoplasms endometrial clinical trials are active in Japan?
There are currently 1 active clinical trials for neoplasms endometrial with sites in Japan, of which 1 are actively recruiting patients.
How can I join a neoplasms endometrial clinical trial in Japan?
To join a neoplasms endometrial clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are neoplasms endometrial trials in Japan?
Active neoplasms endometrial trials in Japan span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global neoplasms endometrial Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology